APA (7th ed.) Citation

DB, C., DB, C., M, M., SH, D., EB, C., C, D., . . . WR, S. (2024). Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary. Pharmacotherapy, 44(5), 354. https://doi.org/10.1002/phar.2913

Chicago Style (17th ed.) Citation

DB, Cluck, et al. "Consensus Recommendations for the Use of Novel Antiretrovirals in Persons with HIV Who Are Heavily Treatment-experienced And/or Have Multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An Executive Summary." Pharmacotherapy 44, no. 5 (2024): 354. https://doi.org/10.1002/phar.2913.

MLA (9th ed.) Citation

DB, Cluck, et al. "Consensus Recommendations for the Use of Novel Antiretrovirals in Persons with HIV Who Are Heavily Treatment-experienced And/or Have Multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An Executive Summary." Pharmacotherapy, vol. 44, no. 5, 2024, p. 354, https://doi.org/10.1002/phar.2913.